Reason for request
Inclusion on the list of medicines reimbursed by National Health Insurance and approved for hospital use.
Clinical Benefit
| Substantial |
The actual benefit of this proprietary medicinal product is substantial. |
Clinical Added Value
| no clinical added value |
VISANNE does not provide an improvement in actual benefit (IAB V) in the therapeutic strategy for endometriosis. |
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
7PSSNWWQKTdQzetf
